Health
High-dose glucocorticoids and IL-6 receptor inhibition reduce COVID-19-associated cytokine storm mortality. – Brinkwire
The Annals of the Rheumatic Diseases, the journal of the European League Against Rheumatism, EULAR, has published findings of an observational study on the treatment of patients with COVID-19-associated Cytokine storm syndrome (CSS). The study demonstrates that a treatment strategy combining intensive immunosuppression (using glucocorticoids and an IL-6 inhibitor) as well as close monitoring dramatically improves patient outcomes when compared to supportive care only.
The study shows that this …
Continue Reading
-
Noosa News22 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months
-
Noosa News24 hours agoGovernment auditors suspected lab was conducting shonky tests on infrastructure projects
-
Business21 hours agoWhat it means for shareholders
-
Noosa News12 hours agoSchools ban e-bikes | Noosa Today